Artículos del autor

solaci

Acute coronary syndromes

Acute Coronary Syndrome: What Is Safer, Antiaggregant Monotherapy or De-Escalation?

For several years it has been shown that 12-month dual antiplatelet therapy (DAPT) is mandatory for patients...
solaci -
Institutional News

Gender Equality in Medicine: What is the Current Situation?

By Women as One: https://womenasone.org/ Everyone is entitled to human rights. However, in 2021 women are still experiencing discrimination in multiple...
solaci -
Acute coronary syndromes

IVUS in Acute Coronary Syndrome: A New Requirement?

The use of intravascular ultrasound (IVUS) has seen exponential growth across registries over the years, combined with...
solaci -
Institutional News

08/03 | LATAM Network of Interventional Women: 4 Simultaneous Educational Activities!

SOLACI and the Latin American Interventional Women Group (Grupo MIL) continue to promote continuing medical education, in this...
solaci -
Structural heart disease

Infective Endocarditis in TAVR: What’s the Best Treatment?

Infective Endocarditis (IE) rate after TAVR ranges from 0.7% to 3.4%, depending on the different analyses, and...
solaci -
Coronary disease

10/03 | Masterclass Medtronic-SOLACI with Gregg Stone: Complex PCI Scenario

We invite you to take part in a new Medtronic-SOLACI masterclass with Dr. Gregg Stone (USA) and...
solaci -
Acute coronary syndromes

Bypass Grafting and Native Coronary Artery Disease Activity

Positron emission tomography (PET) with F sodium fluoride (F-NaF) allows for the assessment of microcalcification activity (MA)...
solaci -
Coronary disease

Webinar SOLACI-CACI@MicroPort: Conquering Complex Coronary Artery Lesions

We invite you to participate in a new educational activity of high scientific level organized by SOLACI...
solaci -